Champions Oncology (CSBR) EV to FCF (2011 - 2026)

Champions Oncology has reported EV to FCF for 16 years, with the latest figure at 37.06 in Q2 2026.

• On a quarterly basis, EV to FCF fell 388.48% year-over-year to 37.06 in Q2 2026; TTM through Apr 2026 was 16.46, a 229.81% decrease from a year earlier, with the FY2026 full-year figure at 16.46, down 229.81% from the prior year.
• EV to FCF was 37.06 for Q2 2026 at Champions Oncology, up from 68.66 in the prior quarter.
• The five-year high for EV to FCF was 945.01 in Q1 2025, with the low at 134.77 in Q4 2024.
• Average EV to FCF over 5 years is 78.04, with a median of 2.46 recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: EV to FCF jumped 1382.78% in 2025, then plunged 388.48% in 2026.
• Over 5 years, EV to FCF stood at 31.05 in 2022, then soared by 333.92% to 134.72 in 2023, then sank by 200.04% to 134.77 in 2024, then soared by 63.04% to 49.81 in 2025, then rose by 25.61% to 37.06 in 2026.
• The last three EV to FCF figures came in at 37.06 (Q2 2026), 68.66 (Q1 2026), and 49.81 (Q4 2025), per Business Quant data.